Suppr超能文献

基于方酸的基质金属蛋白酶-1肽类抑制剂

Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.

作者信息

Onaran M Burak, Comeau Anthony B, Seto Christopher T

机构信息

Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.

出版信息

J Org Chem. 2005 Dec 23;70(26):10792-802. doi: 10.1021/jo0517848.

Abstract

[structure: see text] A series of squaric acid-peptide conjugates were synthesized and evaluated as inhibitors of MMP-1. The cyclobut-3-enedione core was substituted at the 3-position with several functional groups, such as -N(alkyl)OH, -NHOH, and -OH, that are designed to bind to the zinc atom in the active site of the metalloprotease. The 4-position of the cyclobut-3-enedione was derivatized with mono- or dipeptides that are designed to bind in the S1' and S2' subsites of the enzyme, and position the metal chelating group appropriately in the active site for binding to zinc. Positional scanning revealed that -N(Me)OH provided the highest level of inhibition among the chelating groups that were tested, and Leu-Tle-NHMe was the preferred amino acid sequence. A combination of these groups yielded an inhibitor with an IC50 value of 95 microM. For one inhibitor, conversion of one of the carbonyl groups on the cyclobut-3-enedione core to a thiocarbonyl group resulted in a 18-fold increase in potency, and yielded a compound with an IC50 value of 15 microM.

摘要

[结构:见正文] 合成了一系列方酸 - 肽缀合物,并评估其作为基质金属蛋白酶 -1(MMP -1)抑制剂的活性。环丁 -3- 烯二酮核心在 3 位被几个官能团取代,如 -N(烷基)OH、-NHOH 和 -OH,这些官能团旨在与金属蛋白酶活性位点中的锌原子结合。环丁 -3- 烯二酮的 4 位用单肽或二肽进行衍生化,这些肽旨在结合在酶的 S1' 和 S2' 亚位点,并将金属螯合基团适当地定位在活性位点以与锌结合。位置扫描显示,在测试的螯合基团中,-N(Me)OH 提供了最高水平的抑制作用,且 Leu - Tle - NHMe 是优选的氨基酸序列。这些基团的组合产生了一种 IC50 值为 95 μM 的抑制剂。对于一种抑制剂,将环丁 -3- 烯二酮核心上的一个羰基转化为硫羰基导致活性提高了 18 倍,并产生了一种 IC50 值为 15 μM 的化合物。

相似文献

1
Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.
J Org Chem. 2005 Dec 23;70(26):10792-802. doi: 10.1021/jo0517848.
5
7
Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.
J Biol Chem. 2012 Aug 3;287(32):26647-56. doi: 10.1074/jbc.M112.380782. Epub 2012 Jun 11.
9
Role of sulfonamide group in matrix metalloproteinase inhibitors.
Curr Med Chem. 2008;15(4):368-73. doi: 10.2174/092986708783497300.
10
Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approach.
Bioorg Med Chem. 2005 Jul 15;13(14):4527-43. doi: 10.1016/j.bmc.2005.04.051.

引用本文的文献

1
Synthesis and evaluation of squaramide and thiosquaramide inhibitors of the DNA repair enzyme SNM1A.
Bioorg Med Chem. 2021 Sep 15;46:116369. doi: 10.1016/j.bmc.2021.116369. Epub 2021 Aug 25.
3
A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A.
Org Biomol Chem. 2019 Sep 21;17(35):8094-8105. doi: 10.1039/c9ob01133a. Epub 2019 Aug 5.
5
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.
Chem Biol Drug Des. 2011 Aug;78(2):191-8. doi: 10.1111/j.1747-0285.2011.01148.x. Epub 2011 Jun 20.
6
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.
J Mol Recognit. 2010 Mar-Apr;23(2):173-82. doi: 10.1002/jmr.989.

本文引用的文献

6
Regulation of matrix metalloproteinases: an overview.
Mol Cell Biochem. 2003 Nov;253(1-2):269-85. doi: 10.1023/a:1026028303196.
7
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonists.
Org Lett. 2003 Nov 13;5(23):4249-51. doi: 10.1021/ol030104p.
8
Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.
Cardiovasc Res. 2003 Oct 1;59(4):812-23. doi: 10.1016/s0008-6363(03)00516-9.
10
Synthesis and paralytic activities of squaryl amino acid-containing polyamine toxins.
Amino Acids. 2003 Apr;24(3):293-301. doi: 10.1007/s00726-002-0402-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验